Clinical trial Recruiting at 1 site Interventional Ages 20 to 35 Women only

Phenylalanine needs during the follicular and luteal menstrual phases

Official title: Phenylalanine Requirements in the Menstrual Phases

Run by University of British Columbia · NCT07481201 · Data updated 2026-11-12

We will test how much phenylalanine healthy menstruating women (ages 20–35) need during the follicular versus luteal phase of the menstrual cycle.

More Menstrual Cycle trials

Quick facts

Study typeInterventional
Ages20 Years to 35 Years
SexWomen only
Enrollment15 (estimated)
SponsorUniversity of British Columbia
Academic / other
Locations1 site (Vancouver, British Columbia)
StatusRecruiting
StartedMay 1, 2026
Main results expectedDecember 1, 2028
Study endsDecember 1, 2028
Registry record updatedMay 7, 2026
Trial IDNCT07481201 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy menstruating females aged 20–35 with regular 21–35 day cycles, BMI 18–28 kg/m2, not pregnant or breastfeeding and not using hormonal contraceptives or hormone therapy.

Probably not a fit

People using hormonal birth control, hormone therapy, those who are pregnant, breastfeeding, recently postpartum, have irregular cycles, metabolic/endocrine disorders, or who follow non-traditional diets are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study uses the minimally invasive indicator amino acid oxidation method with safe stable isotopes, controlled diets, and simple breath collections to estimate dietary phenylalanine requirements in healthy menstruating females. Participants (minimum 15) will be studied in both the follicular and luteal phases and randomized to a range of phenylalanine intakes (2.5–22.5 mg/kg/day) across multiple study days. Each participant may complete up to seven test days per phase to gather requirement data at different intake levels, and the goal is to enroll at least seven participants per intake level. The protocol is modeled on previously published isotope-based work from the same lab that defined amino acid needs in pregnancy, lactation, and childhood.

Why it matters

Potential benefit: If successful, the results could support female-specific phenylalanine recommendations that account for menstrual-phase metabolic differences and improve dietary guidance.

How similar studies have gone: Related isotope-based indicator amino acid oxidation studies by the Elango Lab and others have been successfully used to determine amino acid requirements in pregnant, nonpregnant, lactating women and children.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* People with menstrual cycles
* Between the ages of 20 to 35y
* Regular menstrual cycle (21-35 day cycle) for the past 12 months
* Body mass index (BMI) of between 18 and 28 kg/m2
* Free from pre-existing health conditions

Exclusion Criteria:

* People who are currently using hormonal birth control or any contraceptive that would affect sex hormones
* People on hormone therapy
* People with an abnormal menstrual cycle history
* People with non-traditional dietary practices
* Recent weight loss/weight gain
* People with a history of endocrine disorders
* People who are pregnant
* People who are breastfeeding
* People who have given birth in the last 18 months
* People who depend on medication that affects normal metabolism. Any medication that alters normal body metabolism would skew the results and compromise the validity of the data set.
* People with a metabolic, neurological, genetic, or immune disorder likely to affect nutritional requirements or overall body metabolism.

Where it's running

  • BC Children's Hospital Research Institute
    Vancouver, British Columbia, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.